🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Watch the latest MMCTS case report: Robotic resection of mediastinal liposarcoma 📊 Skill level: Advanced A 76-year-old man with new onset atrial fibrillation was found to have a well-differentiated liposarcoma. Explore how robotic resection followed by radiation was used to

Hold that breath! Challenging large sarcoma between the two largest arteries in a human, the aorta and the pulmonary artery, deep in the mediastinum; resected completely robotically with 4 teeny tiny incisions. Very quick recovery and cancer free. See our latest video on MMCTS 🤖

“Excrete a fine uric acid paste once a week” youtube.com/shorts/Uri-Hzr…

New tutorial from MMCTS: Robotic resection of a bronchogenic cyst 📊 Skill level: Fundamental Watch the robotic resection of a bronchogenic cyst in a 25-year-old patient. Discovered on a computed tomography scan performed after a motor vehicle accident, the mass was bordered by

Cutting edge technology in thoracic surgery will be discussed #AATS2025 AATS Come check out my talk on “3D Reconstruction and Augmented Reality in Chest Wall Resection: Do They Really Help?” at the Thoracic Masterclass on Chest Wall Surgery

Just attended “Augmented Reality and 3D Reconstruction: Do They Really Help?” by Zaid Abdelsattar, MD, MS, FACS at #AATS2025 . Game changing tools for surgical planning, education, and precision in CT surgery. The future is immersive. #CardiothoracicSurgery

The #Thoracic Masterclass panel discussion on chest wall is underway, moderated by Dr. Gaetano Rocco Memorial Sloan Kettering Cancer Center and Betty Tong, MD MHS. #AATS2025

Thank you AATS #AATS2025 for the opportunity to showcase how we use augmented reality and cutting edge immersive technology to help our patients with chest wall sarcoma and cancer. Standing room only at the masterclass chest wall session! AATS newsletter featured story in pic

If every EGFR+ lung cancer patient in 🇺🇸 gets the best targeted therapy drug; the healthcare costs of this would exceed National Cancer Institute ’s entire budget of $7.22 Billion. Too expensive 🤔 Check out our newest research in JTO & JTO CRR sciencedirect.com/science/articl… The Society of Thoracic Surgeons AATS

If all eligible 🫁cancer patients took this life saving drug it would cost ~1% total US prescription 💊 spending in 2023 ($720 billion) >National Cancer Institute entire budget ($7.2 billion) >6x total 🇺🇸 spending on🫁 cancer rx in 2019 ($1.4 billion) 🤔 tinyurl.com/3ecwcj7v

Only city to produce a president, a pope and this view. Good morning, Chicago ♥️

#AudioVisualAbstract : The Impact of Diagnostic #Laparoscopy on Upstaging Patients with Siewert II and III #GastroesophagealJunction (GEJ) Cancer Jeffrey Velotta MD FACS rdcu.be/enZI1 Zaid Abdelsattar, MD, MS, FACS Syed A. Ahmad

#AudioVisualAbstract : Tumor Spread Through Air Spaces Predicts Survival in Resected Pulmonary #LymphoepithelialCarcinoma DrChen rdcu.be/evFdN Zaid Abdelsattar, MD, MS, FACS Syed A. Ahmad